A qualifying reclassification must be to Category 1 of the Bulk Drug Substances List or an equivalent classification that allows interim compounding of the drug
The 20mg dosage is formulated for patients who require stronger therapeutic support due to insulin resistance, elevated A1C levels, or weight-related metabolic challenges
Looking to personalize your metabolic program
Protocols, timing post-breastfeeding, and Canadian access covered
Our team comprises some of Utahs most experienced healthcare providers, with backgrounds in intensive care, emergency medicine, cardiology, and flight medicine
Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains